Get startedLog in
    Picture of Immix Biopharma logo

    IMMX — Immix Biopharma News Story

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareSpeculativeMid CapNeutral
    All News

    Brief: Immix Biopharma Says Late-Breaking NXC-201 Data Abstract Accepted For Presentation At ASGCT

    Picture of Immix Biopharma logoImmix Biopharma
    04/05/2023 18:49
    May 4 (Reuters) - Immix Biopharma Inc  IMMX.O :
    * IMMIX BIOPHARMA ANNOUNCES LATE-BREAKING NXC-201 CLINICAL DATA ABSTRACT
ACCEPTED
FOR ORAL PRESENTATION AT THE 26TH ANNUAL MEETING OF THE AMERICAN SOCIETY OF GENE
AND CELL THERAPY (ASGCT)

Source text for Eikon:  ID:nGNX1g8TVn 
Further company coverage:  IMMX.O 

 ((Reuters.Briefs@thomsonreuters.com;))

    Recent news on Immix Biopharma

    See all news